Skip to main content

Moderna testing 2 booster shots to protect against Omicron variant, expects data soon

US-based pharmaceutical giant Moderna is studying two booster shot options designed to anticipate mutations similar to the Omicron strain of the coronavirus, which has been designated as a variant of concern by the WHO.

It is already working to test the ability of the current vaccine dose to neutralise the Omicron variant and data is expected in the coming weeks.

“Moderna is already studying two multi-valent booster candidates in the clinic that were designed to anticipate mutations such as those that have emerged in the Omicron variant,” the company said in a statement.

The first candidate (mRNA-1273.211) includes several mutations present in the Omicron variant that were also present in the Beta variant of concern1. Moderna said it has completed dosing in a potentially pivotal safety and immunogenicity study of mRNA-1273.211 at the 50 µg (N=300) and 100 µg (N=584) dose levels.

ALSO READ | PM Modi chairs key meet on Covid-19, vaccination status amid concerns over Omicron variant

A second multi-valent candidate (mRNA-1273.213) includes many of the mutations present in the Omicron variant that were also present in the Beta and Delta variants2. The company has completed dosing at the 100 µg (N=584) dose level and also plans to explore the 50 µg dose level in approximately 584 participants.

Moderna said it will “rapidly advance” an Omicron-specific booster shot, much like its Beta- and Delta-specific boosters.

“A booster dose of an authorised vaccine represents the only currently available strategy for boosting waning immunity,” the company said.

The new coronavirus variant B.1.1.529, dubbed Omicron, was first reported to the WHO from South Africa on November 24, and has also been identified in Botswana, Belgium, Hong Kong and Israel.

ALSO READ | WHO names new Covid variant Omicron; South Africa says travel bans unjustified | Top points

Global authorities have reacted with alarm to the new variant, with the United States, UK and the EU among those tightening border controls as scientists sought to find out if the mutation was vaccine-resistant.

Pfizer and BioNTech said they expect more data on the Omicron strain to determine whether its Covid-19 vaccine would have to be reworked. Johnson and Johnson also said it is closely monitoring emerging strains of coronavirus and is testing the effectiveness of its shot against the new variant.

(With inputs from Agencies)

Comments

Post a Comment

Popular posts from this blog

Naomi Osaka pulls out from next month’s Indian Wells tourney

Naomi Osaka, who said at the US Open that she planned to take a break from tennis, has officially pulled out of next month’s BNP Paribas Open in Indian Wells. Indian Wells is scheduled for October 4-17 after twice being delayed during the coronavirus pandemic. Naomi Osaka pulls out from next month’s Indian Wells tourney (Image Courtesy: Reuters)HIGHLIGHTSOsaka has struggled on court since she withdrew from the French Open in MayThe 23-year-old Japanese player won her first WTA title at Indian Wells in 2018Naomi Osaka pulls out from next month’s Indian Wells tourneyJapanese tennis star Naomi Osaka has withdrawn from the BNP Paribas Open at Indian Wells. Following her loss at the US Open earlier this month, she announced that she would be taking another indefinite break from tennis. The four-time Grand Slam champion fell in the third round of the year’s final major and afterwards told reporters she needed the break to concentrate on her mental health.Osaka has stru...
Post a Comment
Read more

SAI to finalise new core group of athletes for Target Olympic Podium Scheme’s next cycle in October

The SAI said it is holding discussions with the National Sports Federations to finalise the fresh list of athletes in the TOPS core group ahead of its meeting next month. The Developmental Group of TOPS was added last year to groom promising athletes for future Olympics (SAI Media Photo)HIGHLIGHTSInclusion of India’s elite athletes in TOPS core group is being discussed with NSFs: SAIIndia achieved unprecedented success in the Tokyo Olympics this year by winning 7 medalsTarget Olympic Podium Scheme was established in 2014 to funding and support to Olympic-bound athletesA new core group of the Target Olympic Podium Scheme (TOPS) for the next Olympic cycle will be drawn up from among the country”s elite athletes after the earlier one was dissolved at the end of Tokyo Games, the Sports Authority of India (SAI) said on Wednesday. India achieved unprecedented success in the Tokyo Games this year by winning seven medals, including a historic gold in athletics, mainly due to the fun...
Post a Comment
Read more